Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,150 | -523 |
| Depreciation Amortization | 2 | 1 |
| Accounts payable and accrued liabilities | N/A | 62 |
| Other Working Capital | 43 | 77 |
| Other Operating Activity | -206 | -67 |
| Operating Cash Flow | $-1,311 | $-450 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -15 | -6 |
| Investing Cash Flow | $-15 | $-6 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | N/A | 100 |
| Other Financing Activity | 3,249 | 754 |
| Financing Cash Flow | $3,249 | $854 |
| End Cash Position | 1,923 | 398 |
| Net Cash Flow | $1,923 | $398 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,311 | -450 |
| Capital Expenditure | N/A | -6 |
| Free Cash Flow | -1,311 | -456 |